Clotrimazole is an antimycotic imidazole derivative that interferes with cellular Ca 2+ homeostasis. We investigated the effects of clotrimazole on acute lymphoblastic leukemia (ALL) cells. Treatment with 10 M clotrimazole (a concentration achievable in vivo) reduced cell recovery from cultures of all nine ALL cell lines studied (B-lineage: OP-1, SUP-B15, RS4;11, NALM6, REH, and 380; T-lineage: MOLT4, CCRF-CEM, and CEM-C7). After 4 days of culture, median cell recovery was 10% (range, Ͻ1% to 37%) of cell recovery in parallel untreated cultures. Clotrimazole also inhibited recovery of primary ALL cells cultured on stromal feeder layers. After leukemic cells from 16 cases of ALL were cultured for 7 days with 10 M clotrimazole, median cell recovery was Ͻ1% (range, Ͻ1% to 16%) of that in parallel untreated cultures. Clotrimazole was active against leukemic cells with genetic abnormalities associated with poor response to therapy and against multidrug-resistant cell lines. In contrast, mature T lymphocytes and bone marrow stromal cells were not affected. Clotrimazole induced depletion of intracellular Ca 2+ stores in ALL cells, which was followed by apoptosis, as shown by annexin V binding and DNA fragmentation. Thus, clotrimazole is cytotoxic to ALL cells at concentrations achievable in vivo.
Introduction
Residual drug-resistant leukemic cells cause disease recurrence in approximately 20% of children and 65% of adults after intensive chemotherapy for acute lymphoblastic leukemia (ALL).
1,2 Recurrent ALL is particularly resistant to chemotherapy, as is newly diagnosed ALL with BCR-ABL, MLL gene rearrangements or near-haploidy. 1, 2 Thus, the cure rates for ALL cannot be significantly improved unless new drugs are developed that bypass cellular mechanisms of resistance.
The imidazole derivative clotrimazole is an antimycotic agent that modulates cellular ionic signaling pathways that are crucial to cell survival and growth. In blood cells and other cell types, the transduction of external signals via surface receptors triggers the production of inositol (1,4,5)-trisphosphate and the resultant release of Ca 2+ from the endoplasmic reticulum. [3] [4] [5] Normally, this release induces the opening of plasma membrane Ca 2+ channels and activates the intermediate-conductance Ca 2+ -activated K + (IK) channel, allowing Ca 2+ influx from the extracellular space. [3] [4] [5] [6] [7] [8] [9] Clotrimazole disrupts cellular Ca 2+ homeostasis by releasing Ca 2+ from intracellular stores while inhibiting Ca 2+ influx and blocking IK channels. 7, [10] [11] [12] [13] [14] [15] It is being evaluated clinically for the treatment of IK channel-driven erythrocyte dehydration in sickle cell dis- ease 16, 17 and the treatment of secretory diarrheas that involve chloride secretion through IK channels. 18 Interest in clotrimazole as a potential antileukemic compound derives from the following observations. First, clotrimazole suppresses the proliferation of carcinoma and melanoma cell lines and blocks metastasis of melanoma in immunodeficient mice without evident systemic toxicity. 19 Second, clotrimazole has been shown to inhibit normal lymphocyte proliferation, 20, 21 at least partially by blocking IK channels, 15, 22 and it reportedly exerts beneficial effects in patients with rheumatoid arthritis. 23, 24 Importantly, concentrations of clotrimazole and its metabolites that effectively interfere with Ca 2+ metabolism and block IK channels are achievable in vivo. [25] [26] [27] We investigated the effects of clotrimazole on ALL cells and found that the drug markedly suppresses the recovery of ALL cells from culture. This effect was observed both in leukemic cell lines and in primary leukemic lymphoblasts sustained in vitro by bone marrow-derived stroma. Surprisingly, although clotrimazole was reported to inhibit cell proliferation of various cell types without apparent cytotoxicity, 15, 19, 21, 28, 29 its primary mechanism of action in ALL cells was induction of apoptosis.
Materials and methods

Cells
Bone marrow cells were collected at the time of diagnosis (n = 14) or relapse (n = 2) from patients with ALL, ages 1 to 17 years (median, 8 years) (Table 1) . Fourteen cases were B-lineage ALL (CD19 + , CD22
+ and HLA-DR + ); four of these were pre-B ALL (cytoplasmic immunoglobulin heavy chains were present). The remaining two cases were T-lineage ALL (CD3 + ,
CD2
+ and CD7 + ). The viability of cells was Ͼ90% in all samples, as demonstrated by trypan blue dye exclusion. Peripheral blood lymphocytes were obtained from healthy donors. Mononuclear cells were separated by density gradient centrifugation (Lymphoprep, Nycomed, Oslo, Norway) and then washed three times in phosphate-buffered saline and once in AIM-V (Gibco, Grand Island, NY, USA), a serum-free, cytokine-free tissue culture medium. These studies were approved by the St Jude Children's Research Hospital Institutional Review Board, and informed consent was given by the patients, their parents or guardians, or both.
The B-lineage ALL cell lines RS4;11,  30 380,  31 REH,  32 OP1   33 and NALM6 34 and the T-lineage ALL cell lines MOLT-4 35 and CCRF-CEM were available in our laboratory. 36 The cell lines CEM-C7 37 and SUP-B15 38 were obtained from Dr G Melnycovych (University of Kansas Medical Center, Kansas City, MO, USA) and Dr SD Smith (University of Chicago, Chicago, IL, USA), respectively; the drug-resistant subclones of CCRF-CEM (CEM-VLB 100 and CEM/VM-1) 39, 40 were obtained from Dr WM 
Cell culture
Bone marrow stromal cells derived from healthy bone marrow transplant donors were depleted of T cells by CD6-and CD8-mediated rabbit complement lysis. Stroma was prepared in 96-well flat-bottomed plates (Costar, Cambridge, MA, USA) and fed with RPMI-1640, 10% FCS, and 10 −6 m hydrocortisone (Sigma, St Louis, MO, USA), as previously described. [41] [42] [43] [44] To prepare cultures of primary leukemic cells, we removed the media from the bone marrow stroma and washed the adherent cells seven times with AIM-V tissue culture medium. [41] [42] [43] [44] The leukemic cells were then resuspended in AIM-V medium, and 3 × 10 5 to 4 × 10 5 cells were placed on the stromal layer in each well. We then added clotrimazole (Sigma) at the final concentrations indicated in the Results section. Because clotrimazole was originally dissolved at 5 mm in 100% ethanol, we added ethanol to untreated parallel control cultures at the highest concentration used in the test cultures. Cultures were incubated for 7 days at 37°C, 5% CO 2 , and 90% humidity. Cell lines were cultured similarly in RPMI-1640 plus additives as described above, without bone marrow stromal layers, and were incubated with clotrimazole for 4 days.
Cell counting
Primary leukemic cells were counted and immunophenotyped by flow cytometry when the cultures were established and again after 7 days, as previously described. [41] [42] [43] [44] Briefly, cultures were collected by pipetting. B-lineage ALL cells were incubated with anti-CD19 conjugated to fluorescein isothiLeukemia ocyanate (FITC) and anti-CD3 conjugated to phycoerythrin (PE); T-lineage ALL cells were incubated with anti-CD7 FITC. Normal peripheral blood lymphocytes were incubated with anti-CD3 FITC. All monoclonal antibodies and isotypematched nonreactive controls were purchased from Becton Dickinson (San Jose, CA, USA) or Dako (Carpinteria, CA, USA). The cells were washed twice in phosphate-buffered saline with 0.2% bovine serum albumin and 0.2% sodium azide, resuspended in 0.5% paraformaldehyde, and analyzed with a FACScan flow cytometer and Cell Quest software (Becton Dickinson). An identical procedure was used for cell lines except that immunophenotyping was omitted.
We set 'gates' around the area of the light-scatter dot plot that included virtually all leukemic cells. These gates were used to count cells with the same light-scattering properties before and after culture with or without clotrimazole. Cell numbers were corrected for the percentage of cells in each sample expressing a given immunophenotype. Relative cell recovery after drug treatment was expressed as a percentage of the cells recovered from untreated parallel cultures: number of drug-treated cells recovered/number of untreated cells recovered × 100. All results are reported as the mean of two or more experiments.
Detection of apoptosis
DNA fragmentation was assayed as previously described.
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RS4;11 and CEM-C7 cells were lysed by adding 0.5 ml of hypotonic lysing buffer (10 mm Tris, pH 7.4; 1 mm EDTA; 0.2% Triton X-100). Lysate was centrifuged at 11 000 g for 10 min to separate intact from fragmented chromatin. The supernatants and pellets were separated and both were precipitated for 16 to 48 h at −20°C in 50% isopropanol and 0.5 m NaCl. The precipitates were pelleted by centrifugation at 11 000 g for 10 min, air-dried, resuspended in TE buffer (10 mm Tris, pH 7.4; 1 mm EDTA) and heated at 55°C for 10 min. The loading buffer (15 mm EDTA; 2% sodium dodecyl Leukemia sulfate; 50% glycerol; 0.5% orange G) was added to the samples at a ratio of 1:5 (v:v), and the mixture was heated at 65°C for 10 min. The samples and the molecular size marker (123 bp DNA ladder; Gibco BRL, Gaithersburg, MD, USA) were loaded in a 1.5% agarose gel and mobilized electrophoretically. The gels were then incubated for 3 h at 37°C in TBE buffer (0.09 m Tris borate; 0.002 m EDTA) containing DNasefree RNase A (Boehringer Mannheim, Indianapolis, IN, USA; 20 g/ml) stained with ethidium bromide (2 g/ml) for 15 min, washed, and photographed. In this DNA fragmentation assay, intact chromatin is separated from oligonucleosomal fragments by centrifugation. Therefore, in the absence of apoptosis, the gel lane corresponding to the supernatant DNA appears empty.
We also detected apoptosis by incubating cells with FITCconjugated annexin-V (Trevigen, Gaithersburg, MD, USA), 46 according to the manufacturer's instructions, to label phosphatidylserine residues exposed on the cell surface. Cell membrane permeability was visualized by labeling cells with 5tg/ml of propidium iodide (Trevigen) for 15 min at 20°C. 
Measurement of Ca
Results
Effect of clotrimazole on leukemic cell lines
In initial experiments, we measured the effect of clotrimazole on continuously growing leukemic cell lines. At a concentration of 10 m, clotrimazole markedly reduced cell recovery in all nine ALL cell lines studied (Table 2 ). After 4 days of culture, median cell recovery was 10% (range, Ͻ1% to 37%) of that observed in parallel control cultures containing an equivalent concentration of vehicle (0.2% ethanol). The ethanol had no effect on cell recovery at this concentration, as shown by comparison with control cultures to which no ethanol was added (data not shown). Cell recovery was suppressed by clotrimazole in a dosedependent manner in all cell lines (Table 2 ). This effect remained substantial at a concentration of 5 m, at which median cell recovery was 41% (range, 2% to 70%) of that in control cultures. In three cell lines (SUP-B15, OP-1 and RS4;11), cell recovery was reduced 25% or more even at a concentration of 1 m. Importantly, these cell lines carry BCR-ABL (SUP-B15 and OP-1) and MLL (RS4;11) gene abnormalities associated with poor responses to therapy in childhood ALL. 1 To determine whether clotrimazole bypasses common mechanisms of drug resistance, we tested different concentrations of the compound in the multidrug-resistant CEM-VLB 100 cell line, which overexpresses gp-170 P-glycoprotein, 39 and in the CEM-VM1 cell line, which carries a mutation in the topoisomerase II gene that confers resistance to topoisomerase II inhibitors. 40 We then compared the results with those obtained in the parent CCRF-CEM cell line (Figure 1) . In previous experiments with other drugs, 47 CEM-VLB 100 was relatively resistant to daunorubicin (LC 50 40.1 ng/ml vs 2.2 ng/ml in CCRF-CEM cells), whereas CEM-VM1 showed resistance to teniposide (LC 50 16 .8 m vs 0.04 m in CCRF-CEM cells). By contrast, clotrimazole reduced cell recovery by 50% in the parent cell line and the two drug-resistant cell lines at very similar concentrations (LC 50 3.2 m in CCRF-CEM, 1.2 m in CEM-VLB 100 and 1.7 m in CEM-VM1). Finally, the cell lines REH and MOLT-4, which are relatively resistant to corticosteroids (dexamethasone LC 50 Ͼ10 000 nmol/l for both lines), 48 were clearly susceptible to clotrimazole ( Table 2) .
Effect of clotrimazole on primary leukemic lymphoblasts
Because continuously growing cell lines have different proliferative activity and survival requirements than do primary leukemic cells, their susceptibility to antileukemic compounds may differ as well. 49 To test the effects of clotrimazole on leukemic lymphoblasts obtained from patients, we used a culture system in which bone marrow-derived stromal layers supply the growth and survival needs of these cells in vitro. [41] [42] [43] [44] In the absence of drug treatment, 46% to 555% (median, 89%) of the number of input cells were recovered after 7 days of culture. At a concentration of 10 m, clotrimazole markedly reduced cell recovery in all 16 cases of ALL tested: median cell recovery was Ͻ1% (range, Ͻ1% to 16%) of that measured in parallel untreated cultures (Figure 2 ). The effects of clotrimazole remained evident at 5 m (median cell recovery, 6% of control) and 2 m (median cell recovery, 42%).
Notably, clotrimazole was effective in reducing cell recovery in three cases that carried the t(9;22)(q34;q11) (patients 1-3, Table 1 ), one case that had MLL gene rearrangement Clotrimazole reduces recovery of drug-resistant cell lines after culture. Shown are the percentages of cell recovery after 4 days of cultures with various concentrations of clotrimazole, daunorubicin and teniposide, as compared to control cultures without drugs. Data are presented as mean (± sd) of four measurements.
Figure 2
Clotrimazole reduces recovery of ALL cells from patients after culture. Shown are results of ALL cell recovery after 7 days of culture on bone marrow-derived stromal layers in the presence of clotrimazole relative to parallel control cultures without the drug. The data are mean of duplicate experiments. Horizontal bars indicate the median percent cell killing for each concentration of clotrimazole. Intra-assay variability was Ͻ10% in all experiments. All cases were tested with 10 m clotrimazole; other drug concentrations were not tested in all cases.
(patient 4, Table 1 ), and one case with near-haploidy (patient 7, Table 1 ). Median cell recovery was Ͻ1%, 17%, Ͻ1%, 1%, and 8%, respectively, at 5 m clotrimazole, and 1% or less at 10 m clotrimazole. Lower concentrations were also effective: percent cell recoveries for patients 1-4 were 9%, 36%, 38%, and 32%, respectively, at 2 m clotrimazole (cells from patient 7 were not tested at this concentration); cell recoveries after exposure to 1 m clotrimazole were 66%, 58%, 85%, 59% and, for patient 7, 45%.
Clotrimazole did not exert a marked cytoreductive effect on mature CD3
+ T lymphocytes. Recovery of these cells after a 7-day culture with 10 m clotrimazole under identical conditions was 89.9% ± 7.1% (n = 3) of cell recovery in parallel untreated cultures. As previously reported, 15, 20 treatment with clotrimazole interfered with the activation of these cells by phytohemoagglutinin: cell recovery with 10 m clotrimazole was 33.9% ± 11.7% (n = 3) of control cultures.
Clotrimazole induces apoptosis in ALL cells
Previous studies had indicated that at the concentrations used in this study, clotrimazole inhibits cell proliferation but does Leukemia not cause cytotoxicity. 15, 19, 21, 28 However, we observed that leukemic cells treated with clotrimazole consistently showed changes in their light-scattering properties like those caused by apoptosis-inducing antileukemic drugs. 50 The cells' decreased forward light scatter indicated reduced cell size, and their increased orthogonal light scatter indicated increased intracellular granularity (Figure 3 ). Microscopic changes in the cells' morphology, such as nuclear fragmentation, were also typical of apoptosis (Figure 4) .
To determine whether clotrimazole induced apoptosis in ALL cells, we used annexin V binding to detect exposure of phosphatidyl serine residues on cell membrane and assayed fragmentation of DNA in multiples of 180 base pairs. In the six ALL cell lines tested (OP-1, RS4;11, REH, 380, MOLT4 and CEM-C7), annexin V reactivity and cell membrane permeablization were detectable after 24 to 72 h of culture with 10 m clotrimazole ( Figure 5 ). DNA fragmentation was tested in the cell lines RS4;11 and CEM-C7; in both cell lines, massive DNA fragmentation was apparent after 48 h of culture with 10 m clotrimazole ( Figure 6 ). Taken together, these data indicate that apoptosis was the primary cause of reduced cell recovery after culture with clotrimazole.
Clotrimazole depletes intracellular Ca 2+ stores in leukemic lymphoblasts
Clotrimazole releases Ca 2+ from the endoplasmic reticulum and inhibits compensatory Ca 2+ influx, thus inducing a sustained depletion of intracellular Ca 2+ stores. 7, [10] [11] [12] [13] [14] [15] To determine whether clotrimazole affected Ca 2+ homeostasis in ALL cells, we measured changes in cytosolic Ca 2+ concentration in the leukemic cell line 380. Exposure to 10 m clotrimazole induced a detectable increase in cytosolic Ca 2+ concentration, as shown by an increased Indo-1 fluorescence signal ratio; this increase became clearly evident after exposure to 50 m of the drug (Figure 7) . It was detectable approximately 1 min after exposure to clotrimazole and was sustained for at least 8 min.
To determine whether clotrimazole affected Ca 2+ release from intracellular Ca 2+ stores, we added thapsigargin to cells that had been exposed to clotrimazole. Thapsigargin is an inhibitor of endoplasmic reticulum Ca 2+ pumps; it releases Ca 2+ from inositol 1,4,5-trisphosphate-sensitive Ca 2+ pools and disrupts the balance between Ca 2+ influx and efflux through the endoplamic reticulum membrane. 19, 51 Preincubation with 10-50 m clotrimazole for 5 min abrogated the thapsigargin-mediated increase in cytosolic Ca 2+ (Figure 7 ), indicating that the intracellular stores sensitive to thapsigargin had been depleted by clotrimazole. 
Figure 4
Clotrimazole induces apoptosis in ALL cells. The cell line 380 (upper panels) was cultured with or without clotrimazole (10 m). After 72 h of culture, cell death was evident in the presence of clotrimazole, with many cells exhibiting nuclear fragmentation (see insert). In parallel cultures of peripheral blood mononuclear cells (MNC) seeded on bone marrow stroma (lower panels), clotrimazole had no apparent effect on cell viability.
Discussion
We have shown that clotrimazole is cytotoxic to ALL cells. The drug was cytotoxic both to continuously growing cell lines and to primary leukemic cells that had a broad spectrum of immunophenotypes and karyotypes. Cells that were collected at the time of relapse or that carried genetic abnormalities associated with a poor prognosis were as sensitive to clotrimazole as were cells without these features. Importantly, the cytotoxicity of clotrimazole was not affected by common mechanisms of drug resistance that reduce the effectiveness of commonly used antileukemic compounds.
In previous studies that showed the anticancer potential of clotrimazole, the principal cellular effect of the drug appeared to be inhibition of cell proliferation rather than cytotoxicity. Benzaquen et al 19 showed that clotrimazole inhibits in vitro proliferation of human melanoma, lung carcinoma, and colon carcinoma cell lines and inhibits metastasis of engrafted melanoma cells in immunodeficient mice. Khalid et al 28 and Smith et al 29 reported similar effects in glioblastoma and lung fibroblast cell lines, respectively. In ALL cells, by contrast, clotrimazole clearly induced apoptosis when used at concentrations identical to those used in solid tumor cell lines. The apoptotic effect was evident by a variety of criteria, was consistently observed in all cell lines and primary leukemic samples studied, and was detectable after as little as 24 h of exposure to the drug.
As an initial exploration of the mechanism of action of clotrimazole in ALL cells, we investigated whether its previously reported effects on Ca 2+ homeostasis were evident in ALL cells. The effects of clotrimazole in these cells overlapped those previously described in other cell types. 7, [13] [14] [15] 19 That is, clotrimazole induced a rapid and sustained increase in intracellular Ca 2+ concentration and prevented the induction of the same effect by thapsigargin, a compound that releases intracellular Ca 2+ stores. The antiproliferative activity of clotrimazole in other cell types has been attributed to the depletion of Ca 2+ stores and the prevention of Ca 2+ influx mediated by mitogens and IK channels. 15, 19 Because clotrimazole induces apoptosis in ALL rather than inhibiting cell proliferation, other mechanisms may be involved. Changes in intracellular Ca 2+ concentration can result in apoptosis in immature lymphoid cells. 4, 52 Therefore, ALL cells, which are clonally expanded immature lymphoid cells, may be more sensitive to these Leukemia effects than mature lymphocytes and epithelial cells. We observed that bone marrow-derived stromal cells remained attached and morphologically intact even in the presence of 100 m clotrimazole, and mature lymphocytes were unaffected by clotrimazole at concentrations that induced apoptosis in ALL cells. An alternative explanation is that clotrimazole interferes with essential survival-promoting signals derived from the bone marrow stroma in the case of primary ALL cells and from serum factors in the case of cell lines.
Clinical studies of oral clotrimazole have indicated that a plasma concentration of 10 m or more can be achieved by one 1 g oral dose of clotrimazole. 25, 26 Therefore, plasma con-
Figure 6
Clotrimazole induces apoptosis in ALL cell lines. ALL cells RS4;11 and CEM-C7 were cultured with and without 10 m clotrimazole (CLT) for 48 h. The molecular weight marker consists of multiples of 123 basepairs.
Figure 7
Clotrimazole (CLT) induces an increase in intracellular Ca 2+ and depletes Ca 2+ stores. Flow cytometric density plots show changes in Indo-1 ratio (y axes) as a function of time (x axes) in the ALL cell line 380. The steady-state Indo-1 ratio was first recorded. Then, tubes were removed from the nozzle of the cytometer and stimulus was added; this time point is indicated by an arrow. When ethanol (0.1%; the clotrimazole vehicle) was added, no significant changes in Indo-1 ratio were recorded (upper left). By contrast, addition of clotrimazole (50 m) induced changes in Indo-1 ratio suggestive of Ca 2+ flux (upper right); larger changes appear to occur in a minority of cells (darker shades of grey). Ca 2+ flux was also induced by thapsigargin (TG; 3 m; lower right), with large changes occurring in most cells (lighter shades of grey). When cells were pre-incubated with clotrimazole 50 m, the effect of thapsigargin was largely reduced (lower right). Please note that the Indo-1 ratio in this experiment was elevated before the addition of thapsigargin, reflecting the effect of clotrimazole.
centrations that induce apoptosis in ALL cells should be achievable in vivo. The systemic use of clotrimazole at high doses (eg 80 mg/kg per day and higher) may be limited by gastrointestinal and urinary side-effects and elevation of hepatic enzymes and plasma cortisol levels. 17, 23, 25, 53 Some of the most severe side-effects are likely to reflect clotrimazole inhibition of cytochrome P450-dependent enzymes. 27, [53] [54] [55] Interestingly, however, recently developed clotrimazole analogues that have potent and selective IK channel-blocking activity do not inhibit cytochrome P450-dependent enzymes. 56 One of these derivatives, triarylmethane (TRAM-34), has been shown to suppress mitogenesis of activated lymphocytes. 56 If this derivative proves to be equally effective in ALL cells, it will be a strong candidate for clinical testing in cases of high-risk lymphoblastic leukemia that are resistant to conventional therapy.
